~~<i id='F44E11228C'><strike id='F44E11228C'><tt id='F44E11228C'><pre id='F44E11228C'></pre></tt></strike></i>~~

Home» leisure time» comprehensive

comprehensive

author：Wikipedia 2025-09-29 15:57:12 Page View：3199

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul
Next article： United colonoscopy coverage change 'may cost lives,' doctors say

knowledge

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

Hilary expected to bring catastrophic, life

1:58WindblowspalmtreesattheMedanobeachbeforethearrivalofhurricaneHilaryatLosCabosresortinBajaCalifor

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

The pain doctors face in trying to build their families

Adobe“TheRetrievals,”adisturbingpodcastfromSerialandtheNewYorkTimesreleasedthissummer,painstakinglyt